Light transmittance aggregometry with non-adjusted PRP is more suitable for clinical laboratory monitoring antiplatelet therapy

Objective In this study,maximum platelet aggregation rate of Light transmittance aggregometry (LTA) for coronary heart disease (CHD) patients taking antiplatelet drug and patients without antiplatelet therapy was measured in non-adjusted and platelet count-adjusted platelet-